مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

5,830
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

ESTIMATION OF DIRECT MEDICAL COSTS OF HEPATITIS C

Pages

  21-27

Abstract

 Background: Nowadays, HEPATITIS C virus (HCV) is one of the major health problems in Iran and the world. Since HCV treatment is costly and affects the patient’s life, in this study we decided to assess the cost of HEPATITIS C treatment.Materials and Methods: In this descriptive cross-sectional study, we studied 248 medical records of HEPATITIS C patients who admitted in HEPATITIS Clinic related to Baqiyatallah Research Center for Gastroenterology and Liver diseases between 2006 and 2010. We estimated the DIRECT MEDICAL COSTs of HEPATITIS C with these data which extracted from medical records of HCV patients. Also the mean DIRECT MEDICAL COSTs were calculated to achieve sustain viral response (SVR).Results: Mean DIRECT MEDICAL COSTs for the courses treated with conventional interferon-ribavirin (INF-RBV) were 11,544,061 Rial and 66,430,152 Rial for peg-interferon plus ribavirin (PEG-RBV) courses. There was an increase of the direct costs in both courses of treatment in order to achieve SVR. The costs amounted to 26,407,040 Rial in INF-RBV treatment and 112,993,343 Rial in PEG-RBV.Conclusion: Treatment of HEPATITIS C is very costly. Screening and effective interventions in care and management of affected patients can delay complications, decrease the treatment course and the costs of treatment, and also relief patient distress and improve their quality of life.

Cites

  • No record.
  • References

    Cite

    APA: Copy

    ASHTARI, SARA, VAHEDI, MOHSEN, KARKHANEH, MARYAM, ZALI, MOHAMMAD REZA, & ALAVIAN, SEYED MOAYED. (2014). ESTIMATION OF DIRECT MEDICAL COSTS OF HEPATITIS C. MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY, 23(1 (SUPP.)), 21-27. SID. https://sid.ir/paper/98491/en

    Vancouver: Copy

    ASHTARI SARA, VAHEDI MOHSEN, KARKHANEH MARYAM, ZALI MOHAMMAD REZA, ALAVIAN SEYED MOAYED. ESTIMATION OF DIRECT MEDICAL COSTS OF HEPATITIS C. MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY[Internet]. 2014;23(1 (SUPP.)):21-27. Available from: https://sid.ir/paper/98491/en

    IEEE: Copy

    SARA ASHTARI, MOHSEN VAHEDI, MARYAM KARKHANEH, MOHAMMAD REZA ZALI, and SEYED MOAYED ALAVIAN, “ESTIMATION OF DIRECT MEDICAL COSTS OF HEPATITIS C,” MEDICAL SCIENCES JOURNAL OF ISLAMIC AZAD UNIVERSITY, vol. 23, no. 1 (SUPP.), pp. 21–27, 2014, [Online]. Available: https://sid.ir/paper/98491/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top